A Philadelphia jury has returned a verdict against Johnson & Johnson, finding that the company's talc-based baby powder was a substantial contributing factor in the death of a woman who developed ovarian cancer after decades of regular use.
The verdict marks the first time a Philadelphia court has found J&J liable in a talc-related ovarian cancer case. The plaintiff's family presented evidence that the deceased used Johnson's Baby Powder for personal hygiene for over 30 years, and that the product contained trace amounts of asbestos fibers — a known carcinogen.
The Evidence Presented
Plaintiffs' attorneys introduced internal J&J documents showing that the company was aware of potential asbestos contamination in its talc supply chain as early as the 1970s but chose not to disclose the risk to consumers. Expert witnesses testified about the biological mechanism by which asbestos-contaminated talc particles can travel to the ovaries and trigger cancerous cell growth.
Johnson & Johnson maintained its defense that its baby powder is safe and asbestos-free, pointing to decades of testing and FDA reviews. However, the jury was persuaded by the volume of internal communications suggesting the company prioritized sales over safety disclosures.
Impact on the Broader Litigation
This verdict adds significant momentum to the roughly 69,000 pending talc cases nationwide. Legal experts say Philadelphia verdicts carry particular weight because of the city's reputation as a bellwether jurisdiction in mass tort cases. The ruling may increase pressure on J&J to improve its proposed $6.48 billion settlement offer, which many plaintiffs have criticized as inadequate.